Basal acid output and gastric acid hypersecretion in gastroesophageal reflux disease - Correlation with ranitidine therapy

Digestive Diseases and Sciences

Volumn 39, Issue 2, 1994, Pages 410-417

  Collen, Martin J ^a,b,c   Johnson, David A ^a,b,c   Sheridan, Michael J ^a,b,c  

^a LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^c INOVA Health Care System   (United States)

Author keywords

acid output; gastric acid; gastroesophageal reflux disease; hypersecretion; ranitidine

Indexed keywords

RANITIDINE;

ADULT; ARTICLE; BARRETT ESOPHAGUS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOSCOPY; ESOPHAGITIS; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVENTION; PRIORITY JOURNAL; STOMACH ACID SECRETION;

ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; DOSE-RESPONSE RELATIONSHIP, DRUG; DUODENAL ULCER; ESOPHAGITIS, PEPTIC; FEMALE; GASTRIC ACID; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; RANITIDINE;

EID: 0028268097     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/BF02090216     Document Type: Article

References (38)

1. Pathogenesis of reflux esophagitis
2. Mechanisms of gastroesophageal reflux in patients with reflux esophagitis
3. Gastroesophageal reflux: Pathopsychologic concepts
4. Gastroesophageal reflux: Pathogenesis, diagnosis, and therapy
5. Gastric acid hypersecretion and refractory gastroesophageal reflux disease
6. Gastric secretion and reflux pattern in reflux esophagitis before and during ranitidine therapy
7. The significance of gastric secretory state in gastroesophageal reflux disease
8. A critical analysis, with appropriate controls, of gastric acid and pepsin secretion in clinical esophagitis
9. Correlation between basal acid output and daily ranitidine dose required for therapy in Barrett's esophagus
10. Elevated gastric acid secretion in patients with Barrett's metaplastic epithelium
11. Histologic evaluation of chronic gastroesophageal reflux: An evaluation of biopsy methods and diagnostic criteria
12. Barrett's esophagus
13. Basal acid output in patients with gastroesophageal reflux disease
14. Definition for idiopathic gastric acid hypersecretion: A statistical and functional evaluation
15. Idiopathic gastric acid hypersecretion
16. Basal acid output in gastroesophageal reflux disease
17. Refractory duodenal ulcers (nonhealing duodenal ulcers with standard doses of antisecretory medication)
18. Acute treatment of reflux esophagitis: a multicenter trial to compare 150 mg ranitidine, bd with 300 mg ranitidine qds
19. Dose ranging effects of famotidine on gastric acid suppression
20. The efficacy of famotidine 20 mg bid versus 40 mg bid in the treatment of erosive/ulcerative reflux esophagitis: Significance of severity of esophagitis and duration of therapy
21. Management of gastroesophageal reflux disease—are there alternatives to omeprazole?
22. Rational for high-dose H2-receptor blockade in the treatment of gastroesophageal reflux disease
23. Omeprazole vs ranitidine in the treatment of reflux esophagitis. Results of a randomized, double-blind, multicenter French-Belgian study
24. Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind Scandinavian multicenter study
25. Omeprazole and ranitidine in the treatment of reflux esophagitis: Double-blind comparative trial
26. Barrett's ulcer: Response to standard dose ranitidine, high dose ranitidine and omeprazole
27. Healing of chronic Barrett's ulcers with omeprazole
28. Omeprazole (40 mg) is superior to ranitidine in the short-term treatment of ulcerative reflux esophagitis
29. Double-blind multicenter comparison of omeprazole and ranitidine in the treatment of reflux esophagitis
30. Omeprazole in the long-term management of patients with acid related diseases resistant to ranitidine
31. Omeprazole in the long term management of patients with reflux esophagitis, refractory to histamine H2-receptor antagonists
32. Omeprazole in the treatment of erosive esophagitis, refractory to high dose cimetidine
33. Treatment of reflux esophagitis resistant to H2-receptor antagonists
34. Omeprazole in the treatment of erosive esophagitis, refractory to high doses of cimetidine and ranitidine
35. Omeprazole or high dose ranitidine in the treatment of patients with reflux esophagitis, not responding to standard doses of H2-receptor antagonists
36. Prospective evaluation of omeprazole treatment in reflux esophagitis refractory to H2-receptor antagonists
37. Comparison of omeprazole and ranitidine in treatment of refractory gastroesophageal reflux disease in patients with gastric acid hypersecretion
38. High doses of ranitidine in patients with reflux esophagitis